We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Low Frequency Sound Massage Helps Treat Diseases

By HospiMedica International staff writers
Posted on 05 Jun 2012
Vibroacoustic therapy (VAT), which uses low frequency sound, could play a key role in reducing the symptoms of Parkinson’s disease.

Developed by researchers at the University of Toronto (Canada), VAT consists of low sound frequencies that are transmitted to the body and brain through special transducers that convert the sound to an inner body “massage.” VAT frequencies, which range between 20 Hz and 100 Hz, correspond to brainwave activities and function. More...
In 2009, the researchers treated two groups of Parkinson’s patients (20 with dominant tremor symptoms and 20 with slow/rigid movement symptoms) with five minutes of 30 Hz VAT. Both groups showed improvements in all symptoms, including less rigidity and better walking speed with bigger steps and fewer tremors.

However, according to the researchers, the effects of VAT extend beyond the brain. It also provides deep physical cellular stimulation to skin, muscles, and joints, resulting in decreased pain and increased mobility. Similar to mechanical massage, VAT aids circulation, relaxes muscles, and feels good. The researchers added that medical conditions such as Parkinson’s and neuralgic pain such as fibromyalgia might be related to brain-rhythm disorientation between the inner brain and the outer cortex, which the rhythmic pulses of VAT music can drive and stabilize.

“It is basically stimulating the body with very low sound, like sitting on a subwoofer,” said Prof. Lee Bartel, LMus, PhD, director of the music and health research collaboratory (MaHRC) at the University of Toronto. “It is truly an exciting time for music medicine; the idea of developing audioceuticals (prescribable sound) points to a whole new direction for music therapy, and the potential for MaHRC to lead in this is very exciting for me.”

Related Links:

University of Toronto




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.